Salarius Pharmaceuticals Inc (SLRX) Social Stream
SALARIUS PHARMACEUTICALS INC (SLRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SALARIUS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 2 | $5 | $5 | $5 | $0.61 | 719.67% |
| 2022-03-14 | 2 | $5 | $4 | $4.5 | $0.61 | 637.7% |
| 2022-11-14 | 1 | $125 | $125 | $125 | $0.61 | 20391.8% |
| 2023-04-06 | 1 | $5 | $5 | $5 | $0.61 | 719.67% |
| 2023-05-17 | 1 | $17 | $5 | $11 | $0.61 | 1703.28% |
| 2023-07-11 | 1 | $6.75 | $5 | $5.875 | $0.61 | 863.11% |
| 2023-08-09 | 1 | $5 | $3.25 | $4.125 | $0.61 | 576.23% |
| 2023-11-10 | 1 | $3.25 | $3.25 | $3.25 | $0.61 | 432.79% |
Price Target Last Issued April 6, 2023
The Trend in the Analyst Price Target
Over the past 122 days, SLRX's average price target has gone down $2.62.
SLRX reports an average of 427.62% for its upside potential over the past 31 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-09 | 1 | 17.00 | 5.00 | 11.000 | 1.810 | 507.73% |
| 2023-05-17 | 1 | 17.00 | 5.00 | 11.000 | 1.430 | 669.23% |
| 2023-07-11 | 1 | 6.75 | 5.00 | 5.875 | 1.270 | 362.6% |
| 2023-08-09 | 1 | 5.00 | 3.25 | 4.125 | 0.759 | 443.48% |
| 2023-08-11 | 1 | 3.25 | 3.25 | 3.250 | 0.648 | 401.54% |
SLRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
SLRX's average broker recommendation rating worsened by 1.33 over the prior 25 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SLRX has a greater number of analysts covering the stock than 5.66% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, SALARIUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 771.02% of them.
- In terms of how SALARIUS PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 148.86% of that group.
- In terms of how SALARIUS PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -26.89% of that group.
In the Pharmaceutical Products industry, ARAV, ABUS, and LPCN are the three stocks most similar to SALARIUS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for SLRX? Use POWR Ratings for clearer insight into price direction.